{"schema_version":"secwatch.filing_event.v1","accession":"0001730463-25-000095","form_type":"8-K","ticker":"AUTL","cik":"0001730463","company_name":"Autolus Therapeutics plc","filed_at":"2025-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.272680+00:00","generated_at":"2026-05-16T15:45:27.282416+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Autolus appoints former BioNTech CSO Ryan Richardson to Board","bullets":["Ryan Richardson appointed as Class I director effective Dec 1, 2025; served as BioNTech CSO (2018–2025).","Will receive £33,000 annual retainer and initial option grant for 80,000 ADSs at $1.41/ADS, vesting over 36 months.","Richardson led BioNTech's corporate strategy, capital markets, and multiple M&A deals.","Prior roles include Executive Director at J.P. Morgan Healthcare Investment Banking (2011–2018)."],"urls":{"canonical":"https://secwatch.observer/filing/0001730463-25-000095","json":"https://secwatch.observer/filing/0001730463-25-000095.json","markdown":"https://secwatch.observer/filing/0001730463-25-000095.md","text":"https://secwatch.observer/filing/0001730463-25-000095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730463/000173046325000095/0001730463-25-000095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730463/000173046325000095/autl-20251201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:45:27.282416+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}